| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $250K | — |
| R&D Expense | $6.9M | +5.3% |
| SG&A Expense | $6.2M | -29.2% |
| Operating Income | -$13.1M | +16.9% |
| Interest Expense | $15K | +15.4% |
| Income Tax | $0 | — |
| Net Income | -$12.3M | +13.7% |
| EPS (Basic) | -$1.80 | +89.1% |
| EPS (Diluted) | -$1.80 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | +0.4% |
| Current Assets | $13.3M | -9.5% |
| Total Assets | $14.1M | -10.9% |
| Current Liabilities | $2.6M | -14.1% |
| Total Liabilities | $2.7M | -16.6% |
| Stockholders' Equity | $11.3M | -9.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.1M | +16.7% |
| Capital Expenditures | $4K | -60.0% |
| Investing Cash Flow | -$4K | +60.0% |
| Financing Cash Flow | $11.2M | -26.7% |
| Free Cash Flow | -$11.1M | +16.7% |
| +89.1% |